Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Vascular dementia (VaD)"'
Autor:
Huanjia Gao, Elizabeth L. Findeis, Lauren Culmone, Brianna Powell, Julie Landschoot-Ward, Alex Zacharek, Trueman Wu, Mei Lu, Michael Chopp, Poornima Venkat
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
BackgroundVascular Dementia (VaD) refers to dementia caused by cerebrovascular disease and/or reduced blood flow to the brain and is the second most common form of dementia after Alzheimer’s disease. We previously found that in middle-aged rats sub
Externí odkaz:
https://doaj.org/article/4d240e67735245f18c3348a404bafd5b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Min Gong, Jianping Jia
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2022)
BackgroundAlzheimer’s disease (AD) and vascular dementia (VaD) are the two most common types of neurodegenerative dementia among the elderly with similar symptoms of cognitive decline and overlapping neuropsychological profiles. Biological markers
Externí odkaz:
https://doaj.org/article/3717d9ae3bc94d6cb57a7d758e63ac8e
Autor:
Shouzi Zhang, Yuanyuan Wang, Lixin Liu, Li Zhang, Li Ma, Haiyan Wu, Xuelin He, Mingwei Zhu, Luning Wang, Fan Mei
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Vascular Parkinsonism(VaP) is defined as parkinsonism resulting from cerebral vascular disease(CVD), with presence of variable motor and non-motor signs that are corroborated by clinical, anatomic or imaging findings of cerebrovas
Externí odkaz:
https://doaj.org/article/8951dc406a5c43bd8f0f30f2add475eb
Autor:
Lauren Culmone, Brianna Powell, Julie Landschoot-Ward, Alex Zacharek, Huanjia Gao, Elizabeth L. Findeis, Ayesha Malik, Mei Lu, Michael Chopp, Poornima Venkat
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 16 (2022)
Background and PurposeVascular dementia (VaD) is a complex neurodegenerative disease affecting cognition and memory. There is a lack of approved pharmacological treatments specifically for VaD. In this study, we investigate the therapeutic effects of
Externí odkaz:
https://doaj.org/article/0dcae1863447444884ed69c8aad92abb
Autor:
Lucía Torres-Simón, Sandra Doval, Alberto Nebreda, Sophia J. Llinas, Elisabeth B. Marsh, Fernando Maestú
Publikováno v:
NeuroImage: Clinical, Vol 35, Iss , Pp 103040- (2022)
Vascular Cognitive Impairment (VCI) is the second most prevalent dementia after Alzheimer’s Disease (AD), and cerebrovascular disease (CBVD) is a major comorbid contributor to the progression of most neurodegenerative diseases. Early differentiatio
Externí odkaz:
https://doaj.org/article/478b283ae5764c9ca5a713dfae0ace22
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Vascular Dementia (VaD) is a neurocognitive disorder caused by reduced blood flow to the brain tissue, resulting in infarction, and is the second most common type of dementia. The complement and coagulation systems are evolutionary host defence mecha
Externí odkaz:
https://doaj.org/article/a2f1d19b478f45a9b3c6d513af8e3a22
Autor:
Lorena Jiménez-Sánchez, Olivia K. L. Hamilton, Una Clancy, Ellen V. Backhouse, Catriona R. Stewart, Michael S. Stringer, Fergus N. Doubal, Joanna M. Wardlaw
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Cerebral small vessel disease (SVD) is a common cause of stroke, mild cognitive impairment, dementia and physical impairments. Differences in SVD incidence or severity between males and females are unknown. We assessed sex differences in
Externí odkaz:
https://doaj.org/article/3bf4caf4b5004840995cd81234dc745d
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Vascular dementia (VaD) constitutes the second most prevalent cause of dementia in the world after Alzheimer’s disease (AD). VaD regroups heterogeneous neurological conditions in which the decline of cognitive functions, including executive functio
Externí odkaz:
https://doaj.org/article/89651896aa4e4ef9835c3d6cba69ae1d
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Introduction: The diagnosis and treatment of dementia is one of the greatest challenges in contemporary health care. The widespread use of dementia biomarkers would improve the quality of life of patients and reduce the economic costs of the disease.
Externí odkaz:
https://doaj.org/article/7ddcf565432f4c7e9c9a520359781f82